静脉注射胺碘酮致肝损伤1例报告

张文颖; 徐验; 舒冰

doi:10.3969/j.issn.1001-5256.2018.05.034

静脉注射胺碘酮致肝损伤1例报告

DOI: 10.3969/j.issn.1001-5256.2018.05.034

1. 深圳市孙逸仙心血管医院药剂科
2. 深圳市孙逸仙心血管医院CCU
3. 安徽省立医院药剂科

基金项目:

深圳市卫生计生系统科研项目(SZFZ2017045)；

详细信息

中图分类号: R575
计量
- 文章访问数: 1999
- HTML全文浏览量: 5
- PDF下载量: 371
- 被引次数: 0
出版历程
- 出版日期: 2018-05-20

A case of liver injury due to intravenous injection of amiodarone

Department of Pharmacy, Shenzhen Sun Yat-sen Cardiovascular Hospital

Research funding:

摘要

摘要: <正>胺碘酮是Ⅲ类抗心律失常药物,由于其无负性肌力、改善冠状动脉舒张功能的作用,被广泛用于心力衰竭或心肌缺血患者心律失常的治疗。静脉应用胺碘酮的不良反应主要包括:肝损伤、QT间期延长、房室传导阻滞、低血压等。现报道1例急性ST段抬高型心肌梗死伴心力衰竭患者静脉应用胺碘酮过程中发生肝损伤,提示临床药师应提升对伴缺血性肝损伤高危因素的心力衰竭患者使用胺碘酮发生肝损伤时药物不良反应的鉴别意识,注意结合患者肝缺血情况和药物特点,充分评估
- 胺碘酮 /
- 药物性肝损伤 /
- 心力衰竭 /
- 病例报告
- amiodarone /
- drug-induced liver injury /
- heart failure /
- case reports

HTML全文

参考文献(12)

[1]YUAN L, YANG YG, SHEN YX, et al.Research advances in drug-induced liver injury[J].J Clin Hepatol, 2017, 33 (2) :375-378. (in Chinese) 袁玲, 杨永耿, 沈有秀, 等.药物性肝损伤的研究进展[J].临床肝胆病杂志, 2017, 33 (2) :375-378.

[2]National Iinstitute of Diabetes and Disgesive and Kidney Diseases.Drug Record-Amiodarone[DB/OL].http://livertox.nlm.nih.gov/Amiodarone.htm#casereport.2018-01-18/2018-02-11.

[3]RTZ BRAVO AE, DREWE J, SCHLIENGER RG, et al.Hepatotoxicity during rapid intravenous loading with amiodarone:description of three cases and review of the literature[J].Crit Care Med, 2005, 33 (1) :128-134.

[4]Drug-induced Liver Disease Study Group, Chinese Society of Hepatology, Chinese Medical Association.Guidelines for the management of drug-induced liver injury[J].J Clin Hepatol, 2015, 31 (11) :1752-1769. (in Chinese) 中华医学会肝病学分会药物性肝病学组.药物性肝损伤诊治指南[J].临床肝胆病杂志, 2015, 31 (11) :1752-1769.

[5]PAUDEL R, DOGRA P, SUMAN S, et al.Acute liver and renal failure:a rare adverse effect exclusive to intravenous form of amiodarone[J].Case Rep Crit Care, 2016, 2016:5232804.

[6]THIELE RH, WILLIAMS J, MOYLAN CA, et al.Suspected amiodarone hepatotoxicity after cardiac surgery[J].J Cardiothorac Vasc Anesth, 2012, 26 (4) :729-732.

[7]KICKER JS, HAIZLIP JA, BUCK ML.Hepatotoxicity after continuous amiodarone infusion in a postoperative cardiac infant[J].Pediatr Pharmacol Ther, 2012, 17 (2) :189-195.

[8]SPENCE MM, POLZIN JK, WEISBERGER CL, et al.Evaluation of a pharmacist-managed amiodarone monitoring program[J].J Manag Care Pharm, 2011, 17 (7) :513-522.

[9]CATALDI A, GONELLA D, ROBUTTI N, et al.Hepatotoxicity after intravenous amiodarone[J].Aging Clin Exp Res, 2008, 20 (6) :593-596.

[10]NASSER M, LARSEN TR, WAANBAH B, et al.Hyperacute drug-induced hepatitis with intravenousamiodarone:case report and review of the literature[J].Drug Healthc Patient Saf, 2013, 5:191-198.

[11]TANG GD.A case of anaphylactic shock induced by intravenous amiodarone[J].Trauma Crit Med, 2016, 4 (3) :192. (in Chinese) 康国栋.静脉泵入胺碘酮致过敏性休克1例[J].创伤与急危重病医学, 2016, 4 (3) :192.

[12]GLUCK N, FRIED M, PORAT R.Acute amiodarone liver toxicity likely dueto ischemic hepatitis[J].Isr Med Assoc J, 2011, 13 (12) :748-752.

施引文献

资源附件(0)

访问统计